cerebroprotectant formerly known neuroprotectant drug intended protect brain onset acute ischemic stroke second largest cause death worldwide leading cause adult disability drugs tested clinical trials provide cerebroprotectants tested clinical trials two cerebroprotectants approved though several clinical trials drugs ongoing approval rate less low compared overall approval rate drugs brought clinical trials disease areas also much lower relatively high success rate devices treat acute ischemic stroke least different clot removal devices approved since many theories causes low approval rate cerebroprotectants many strategies suggested publications improve chance approval drugs development strategies journals suggest improve chance approval clinical trials outlined httpsenwikipediaorgwikicerebroprotectant